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Risk assessment is a reasoned, structured approach to address uncertainty based on
scientific and technical evidence. It forms the foundation for regulatory decision-making,
which is bound by legislative and policy requirements, as well as the need for making
timely decisions using available resources. In order to be most useful, environmental
risk assessments (ERAs) for genetically modified (GM) crops should provide consistent,
reliable, and transparent results across all types of GM crops, traits, and environments.
The assessments must also separate essential information from scientific or agronomic
data of marginal relevance or value for evaluating risk and complete the assessment
in a timely fashion. Challenges in conducting ERAs differ across regulatory systems –
examples are presented from Canada, Malaysia, and Argentina. One challenge faced
across the globe is the conduct of risk assessments with limited resources. This challenge
can be overcome by clarifying risk concepts, placing greater emphasis on data critical
to assess environmental risk (for example, phenotypic and plant performance data
rather than molecular data), and adapting advances in risk analysis from other relevant
disciplines.
Keywords: genetically engineered crops, GMO, non-target organisms, risk assessment, risk characterization, risk
management
Introduction
Environmental risk assessment (ERA) utilizes a reasoned, structured approach to address uncer-
tainty based on scientific and technical evidence (Wolt et al., 2010). It forms the foundation for
regulatory decision-making, which is bound by legislative and policy requirements. It also responds
to needs for risk managers to make timely decisions using available resources. The ERA process,
which consists of problem formulation, hazard and exposure evaluation, and risk characterization,
has been shown to be useful for a broad array of environmental issues.
In problem formulation, policy requirements and protection goals are identified and defined,
existing data are gathered and reviewed for utility, conceptual models are developed to identify
exposure pathways and potentially affected organisms and/or biological systems, and significant
areas of uncertainty are identified. When conducted properly, the problem formulation phase will
result in a clear identification of critical uncertainties and a plan to address those uncertainties. If it
is determined in problem formulation that additional data are needed tomake a decision onwhether
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the risk is acceptable or unacceptable, then hypothesis-based
research plans are developed to reduce any remaining critical
uncertainties (Raybould, 2006; Wolt et al., 2010).
During risk characterization, research plans are implemented to
gather hazard and exposure data. Many regulatory systems utilize
a tiered approach to increase the efficiency of data collection for
potential hazards (Romeis et al., 2006). Early tier tests conducted
with surrogate species use exposure levels, which exceed expected
environmental conditions to identify potential taxa of concern.
These taxa can then be tested using more realistic testing scenar-
ios. Risk analysis combines exposure and hazard data to evaluate
the potential for the occurrence of unacceptable adverse effects
under real world conditions. The risk analysis report must be
transparent as to how the hazard and exposure data were gathered,
what assumptions were made, and how risk was determined.
A critical task in the ERA process is clearly separating essential
information from data of marginal relevance or value for evaluat-
ing risk [OGTR (Office of theGene Technology Regulator), 2013].
Some datamay be of high quality, but not relevant to the questions
being asked in the assessment. Other data may be of low or uncer-
tain quality and not useable for the assessment. However, data that
are not directly applicable, fully conclusive, or of lower quality
may at times be useful as part of a weight of evidence approach
that can contribute to understanding risk. Data may also need
to be gathered because of legislative requirements or regulatory
guidelines. And lastly, at times data are gathered in response to
public pressure or simply in the personal interest of risk analysts or
managers. The challenge is to understand which data are needed
to reduce critical uncertainties in the risk assessment. The ideal
process to build a “fit for purpose” risk assessment would be one
that gathers and evaluates only the data required to make the risk
decision. For best results, this information should be communi-
cated in a fashion to facilitate decision-making, communication
of the rationale supporting the decision, and implementation of
any future actions.
While the steps of risk assessment are constant, the underlying
process must be adapted to accommodate different genetically
modified (GM) organisms being evaluated within a variety of
legal and cultural scenarios. Examples of adaptation are evident
in the following case studies: evaluation of a novel trait in Canada,
evaluation of a GM insect in Malaysia, and a shift from evaluation
of imported events to cultivation of locally developedGM crops in
Argentina. In each case, the basic approach remained the same and
steps were taken to make the assessment as efficient as possible
while still being responsive to local needs.
Case Study: Plants with Novel Traits
in Canada
Under current regulations, Canada evaluates all “plants with novel
traits” (PNTs) – those plants into which one or more traits have
been intentionally introduced, the introduced trait is new to the
cultivated crop in Canada, and the trait has the potential to
affect the use and safety (environment, human, animal) of the
plant (Macdonald and Yarrow, 2003; Macdonald, 2011). This
evaluation includes but is not limited to GM crops. The focus
in the assessment is a specified use of a certain product, not the
process used to develop the product. A pre-market evaluation
may be triggered by breeding techniques used to create new crop
varieties, for example, conventional breeding including the use of
chemical mutagens for variety development, new plant breeding
techniques, such as genome editing with TALENs or CRISPRs,
and genetic engineering. The pre-market assessment is conducted
under the authority of three acts in Canada: the Seeds Act is the
authority under which environmental assessments are conducted;
the Feeds Act is the authority for the livestock feed assessments;
and the Food andDrugsAct provides the authority for food assess-
ment. The overarching authority for biotechnology regulation in
Canada derives from theCanadian Environmental ProtectionAct.
The biotechnology regulatory process is designed to be trans-
parent, consistent with international standards, conducted on a
case-by-case basis, and science. An important regulatory goal is
to ensure that the regulatory system has adequate safeguards to
protect human and livestock health and the environment, but
does not prevent Canadians from accessing the potential benefits
of the products of biotechnology. The challenge has been and
continues to be to create a regulatory system that can efficiently
evaluate and make decisions on a large number and wide range
of potential novel organisms, learn from experience, and adapt
as technology evolves. As a consequence, safety assessments that
meet regulatory needs for PNTs focus on the novel trait and the
“need to know” factors associated with critical uncertainties in the
safety assessment. The overall safety assessment process remains
the same, whatever breeding technologies were used to develop
the PNT. During problem formulation it is determined if there
are realistic routes to harm and what data are required to test
hypotheses that allow one to predict the likelihood and severity
of harm to assessment endpoints associated with protection goals.
The focus of the safety assessment is also determined by the end
use of the PNT. For most PNTs, a review will be triggered for
all relevant groups of risk assessors. For some PNTs, only certain
groups within the agencies review the novel crop. Examples are
(1) a novel turfgrass would undergo an environmental assessment
and may trigger a feed assessment, but not be evaluated as a novel
food; (2) a GM forage crop would be evaluated as a novel feed and
would undergo an environmental assessment, but would not likely
be evaluated as a novel food; (3) a crop, such as GM cotton, would
undergo a novel food and feed assessment, but the environmental
assessment would beminimal as it would only consider incidental
(and transitory) exposure because cotton is neither cultivated nor
persistent in Canada.
Problem formulation is used to focus the comparative safety
assessment on the differences between the PNT and the con-
ventional counterpart. In this process, a reasonable comparator,
usually the unmodified counterpart to the PNT, is chosen and
differences between the PNT and the comparator are considered
as to whether they represent a probable route to a potential
harm. Data are used to evaluate effects on assessment endpoints
that relate to the risk hypotheses. The identification of potential
hazards is structured under five broad considerations: weediness
potential, gene flow to related species that could become a weed,
potential for the PNT to become a plant pest, impact on non-
target organisms, and impact on biodiversity. The amount of data
that are required to evaluate the effects on assessment endpoints
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is determined on a case-by-case basis. If the PNT is familiar and
the change is not very complex or is similar to other crops that
have already been considered, then the data requirements can be
reduced and linkages to existing data can be made. After the PNT
is authorized for unconfined release, it can be used in traditional
breeding programs to develop new varieties without additional
environmental assessment, though there is a requirement to notify
the CFIA if any new information regarding the environmental
safety of the PNT becomes available.
It is apparent that the case-by-case comparative approach has
served very well for the risk assessment of GM crops in Canada:
approximately 100 PNT have received commercial authorization
since 1996. This process has been shown to be useful to eval-
uate and reliably predict the potential effects of the intended
change and the potential effects of unintended changes. It takes
into account previous experience with insertional effects, normal
plant genetic variability, and change over time (including rate of
spontaneous mutations, chromosome loss, etc.).
Worldwide, there is growing familiarity with GM crops, foods,
and feeds. Coupled with a growing body of research on genetic
engineering and fueled by the rapid advancements in molecular
analysis techniques, this has provided an unprecedented under-
standing of plant genomes and genetic change. Canada continues
to refine its regulatory process. For example, regulators consid-
ered that molecular characterization of a GM crop could be an
important component of the risk assessment for environmen-
tal, food, and feed safety and so established that component
as an area for refinement. A project was initiated to evaluate
the potential outcomes of inserting a new gene into a plant in
the context of the changes that will occur in a plant genome
either spontaneously or through other more conventional forms
of plant breeding. This project resulted in a recent publication
that examines insertional mutagenesis from transgene insertion
in context with the normal changes that can occur in a plant
genome and concluded that the risk level for insertional effects
is similar to other genetic changes in plants (Schnell et al., 2015).
This information helps risk managers place any effects from
insertions into the proper context when making regulatory deci-
sions. Further refinements in the regulatory oversight of PNTs
are expected as Canada continues to ensure a fit for purpose
approach.
Case Study: Genetically Modified
Mosquitoes in Malaysia
Dengue, carried by Aedes aegypti, is a significant public health
issue with approximately 50–100 million infections occurring
each year, resulting in over 20,000 deaths (WHO, 2012). A con-
trol strategy was developed where GM male mosquitoes (Strain
OX513A) that are dependent on regular doses of tetracycline
for survival would be released into the environment where they
wouldmate with wild-type females and produce larvae that would
not develop into adults (Lacroix et al., 2012). The GM males
would then die within days after release. The system worked
well under laboratory conditions; however, additional data were
needed since significant differences in behavior in natural condi-
tions could affect the efficacy of the control strategy. A study was
designed where approximately 6000 modified and 6000 unmod-
ified male mosquitoes would be released into an uninhabited
area of Malaysia. Each of the mosquitoes would be marked using
a fluorescent marker and the OX513A mosquitoes could also
be identified using PCR. Sampling stations would be located at
various distances from the release point and samples taken over a
period of time.
Three major requirements had to be met before the study
could be conducted: an ERA was needed for the release location,
Malaysian regulations required an extensive public communica-
tion program, and a final regulatory decision to approve the field
trial was needed quickly (<180 days) to meet study timelines.
The Genetic Modifications Advisory Committee gathered and
evaluated existing data and conducted the ERA. Data were avail-
able from laboratory studies, a previously conducted semi-field
(caged) mark-recapture study using fluorescent dye, a literature
review, a field release study conducted previously in another envi-
ronment in the Cayman Islands (Harris et al., 2011), and a review
of the qualifications of the research team. Previous risk-benefit
analyses for this technology that indicated that the potential bene-
fits outweigh the theoretical environmental risk were reviewed for
their applicability to the proposed Malaysian study (Beech et al.,
2009; Vasan, 2010; Morris, 2011; Reeves et al., 2012). No major
risks were identified in the science-based ERA and this was com-
municated to the risk managers (National Biosafety Board; NBB).
A public communication program was designed to gather
information about public concerns related to environmental safety
andhumanhealth. Challenges inworkingwith the public included
an expectation of zero risk and also misconceptions and spec-
ulations as to what might happen in the trial. These challenges
were addressed via extensive communication with various public
groups and media representatives. As summarized by Subrama-
niam et al. (2012), the public communication effort included
(1) multiple public announcements in national newspapers in
two languages, (2) direct invitations to nine environmental non-
government organizations (NGOs) for comments and invitations
to face-to-face meetings, (3) a 30-day public comment period,
(4) posters in four languages were placed in local areas near the
study site, and (5) meetings organized with both local govern-
ment councils and local residents. The information gathered from
these communication efforts was then supplied to the NBB for
evaluation. Some groups were supportive of the technology, some
groupswere neutral, and somewere concernedwith the use ofGM
technology to control dengue.
Once the science-based ERA and societal input were available,
the NBB evaluated the information and made a decision to move
ahead with the field release study subject to various restrictions
(single uninhabited site, increased efforts to make sure only male
mosquitoes were released, and fogging the site with insecticides
at the end of the study). Information describing the decision
and the study was then placed on the NBB website and a press
conference held. By focusing on relevant issues, the ERA was
conducted quickly, a public communication campaign was com-
pleted effectively, a regulatory decision was made that took into
account both scientific information and societal influence. The
studywas conducted successfully and results of the study indicated
that dispersal distances and longevity were similar between the
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two strains. This information can then be used in future ERAs as
the GMmosquito project advances.
Case Study: Redesign of the Assessment
Framework in Argentina
Argentina was one of the first countries to approve the cultivation
of GM crops and is currently the third largest producer of GM
crops in the world – in 2012 a total of 24.4 million hectares
were planted with soybean, maize, and cotton (James, 2013).
Regulation of GM crops first began in 1991 under the National
Advisory Commission on Agricultural Biotechnology. While in
some ways similar to other countries, the Argentinian regulatory
process was influenced by locally defined protection goals and
societal attitudes. This resulted in a regulatory process with some
differences compared to the countries where the technology was
originally developed orwhere the regulatory process was designed
to evaluate imported grain. In the early 1990s, evaluations in
Argentina were designed to assess the potential environmental
risk associated with research trial plots. The first commercial
release of a glyphosate tolerant soybean was authorized in 1996
andwas followed in 1998 byGMmaize and cotton. As the number
of applications increased, the Biotechnology Office was estab-
lished in 2004, and then in 2008 theBiotechnologyDirectoratewas
established. The changes in the regulatory structure reflected the
history of GM crops in Argentina. GM crops originally cultivated
in Argentina were developed based on technologies developed
overseas, which were adopted into local agricultural production.
This means that, in most cases, a significant proportion of regu-
latory data used in making decisions in Argentina was generated
for submissions made previously in other countries. Over time,
however, the balance has shifted from crops developed using
imported technologies toward locally developed crops. This shift
was helped in part by support from the government in terms of
incentives to create partnerships to support new biotech startup
companies. The production of many new GM crops and varieties
developed locally are now moving forward rapidly. Drought tol-
erance, virus and insect resistance, and herbicide tolerance has
been engineered into biotech sugarcane, maize, soybean, wheat,
potatoes, and several events are in a medium or advanced stage of
deregulation in Argentina.
The challenge over the past 25 years has been to evaluate
an increasing number of regulatory submissions on increasingly
wider types of crops and varieties. Organizational changes could
only go so far in terms of being able to respond to the increased
rate and complexity of submissions. In 2012, a new regulatory
framework was implemented with a goal of reducing the time
needed to evaluate submissions. This change necessitated not just
an organizational change, but an increased focus on collecting
and evaluating information in a more efficient manner. Examples
of changes in procedure and regulatory philosophy include (1)
originally crops were expected to be substantially equivalent, but
now substantial equivalence is used as a tier in the risk assessment
and new criteria are in place to evaluate crops that are not sub-
stantially equivalent; (2) previously any gene flow was viewed as
directly harmful, now gene flow is regarded as a potential pathway
to harm if a definite hazard has been identified under a proper
risk hypothesis; (3) under the new framework, requirements vary
on a case-by-case basis (e.g., data requirements for contained
greenhouse use are different than those for open cultivation); and
(4) new regulations and assessment criteria have been developed
for special cases like stacks, RNAi, and NBT (new breeding tech-
nologies) crops. This focus on how to gather data in the most
efficient possible way and to use only data that are really needed
to ensure biosafety and make a regulatory decision has decreased
the amount of time needed to evaluate a submission and provide
the required information to risk managers (Lema, 2014).
Conduct of ERA with Limited Resources
One common factor for ERAs wherever they may be conducted is
limited resources, such as time, funding, and expertise. Temporal
limits may be related to commercial development timelines, agro-
nomic needs (e.g., response to a pest outbreak), or legislative or
procedural limits within a regulatory agency. Funding limitations
are common in industry, academia, and government. Limitations
on expertise continue in many areas of the world for several
reasons. Staffing may be limited by available funds, facilities, or
lack of experts available within a certain geography or technical
area. Also, little may be known about a crop, an agro-ecosystem,
target and non-target organisms, or a new trait.
A common response is a call for additional resources to conduct
ERAs in low-income countries. However, the considerable
disparity of resources between high- and low-income countries
is not necessarily reflected in the quality of the risk assessments.
The availability of better resources in high-income countries
has supported the demand for ever-increasing volumes of data,
creating unrealistic expectations, and misleading benchmarks for
ERAs in low-income countries. In some cases, there is a desire to
identify every change that results from the genetic modification
or to continue collecting data until all uncertainty is eliminated
(an unattainable goal). This approach neglects the value and
importance of fit for purpose ERA where resource utilization
is driven by focusing on what is needed to make a sound risk
management decision.
A regulatory submission typically contains a large amount of
data, including general information about the crop,molecular and
protein characterization, composition, response to diseases and
pests, spectrum of activity for insecticidal traits, and information
on potential weediness and invasiveness. These data varywidely in
their importance in terms of helping to make a decision regarding
environmental risk. For example, the phenotype of a plant (char-
acteristics that affect establishment, reproduction and dispersal,
or potential harm) is far more useful than molecular data, which
rarely contribute to the identification of important risks.
Indeed, the risk assessment should clearly distinguish impor-
tant risk from minimal or trivial risk, so that the degree of con-
sideration is aligned with the level of risk. For example, guid-
ance on the identification of significant risks can be obtained
from experience with conventional breeding outcomes of equiv-
alent traits (e.g., insect resistance, herbicide tolerance, or stress
tolerance), and by incorporating established weed risk assess-
ment techniques for determining risk from any type of plant
(Keese et al., 2014). Simple decision-making tools, such as
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checklists, decision trees, and concept mapping, can be used
to support a structured approach to risk assessment in order
to clearly communicate reasoning and acknowledge remaining
uncertainty (Keese, 2013).
Discussion and Conclusion
Beginning the risk assessment process with problem formulation
is key to focusing on essential data (Wolt et al., 2010). The first
step in problem formulation is to define the context of the risk
assessment – understand the protection goals, summarize what
is already known about the crop and trait, and define the envi-
ronment for the assessment. Well-defined protection goals will
greatly assist the risk assessor. For example, if the protection
goal is to protect certain species at a defined level of exposure,
then this focuses the assessment process on a narrow range of
hazard and exposure scenarios. Useful assessment endpoints can
be established and potential endpoints that would cost resources
but not provide useful information can be eliminated. The level
of precision required can be determined in advance to avoid
spending time and energy in an attempt to quantify with high pre-
cision if a decision will be made based on the basis of whether or
not a threshold is exceeded. Summarizing the currently available
information relevant to the defined protection goals makes sure
that time is not spent developing answers to questions that have
already been answered elsewhere. Definition of the environment
allows the risk assessor to focus efforts on answering questions for
the case at hand – so that, for example, if the assessment is for
imported grain that will be processed near a port facility, then the
assessor does not spend time answering “what if ” questions related
to widespread long-term cultivation of that crop. The second step
in problem formulation is to develop an assessment plan. This
plan uses a conceptual model to identify and develop testable
hypotheses to address areas of critical uncertainties. An analysis
plan is then designed that can be used to continually maintain
focus on the areasmost important tomaking the riskmanagement
decision. Perhaps the most important thing to remember during
the risk assessment is that the goal is not to gather information, but
rather to test relevant hypotheses to provide specific information
that will be useful to the risk manager.
Risk assessors and managers involved in each of the case stud-
ies described above faced different cultural, legislative, scientific,
and resource challenges. In each example, ways were found to
focus the assessment process on obtaining information impor-
tant to making the risk management decision and to reduce
use of valuable resources on lower-value data and activities. In
Canada, there was a focus on defining harm and areas of crit-
ical uncertainty and then recognizing which groups within the
government agencies could respond most effectively. In Malaysia,
it was recognized early in the process that a successful outcome
would only occur if an extensive public communications effort
was developed in parallel with the ERA. In Argentina, the choice
was made to move away from a single process to a case-by-case
approach; a new framework was developed to evaluate crops and
traits and focus on data in each case to make a risk manage-
ment decision. In each case, efficiency of the regulatory process
was greatly increased. Understanding that not all data are of
equivalent value and focusing on data that are most relevant to
making a risk management decision can alleviate some resource
constraints by making the risk assessment and risk management
process more efficient. Better ERAs in both high- and low-income
countries can be built by focusing on: information that is rel-
evant to identifying important risk (typically phenotypic data);
applying a degree of effort that is proportional to the level of
risk; and using effective processes to reach sound regulatory
decisions.
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